hydrazine has been researched along with Cytomegalovirus in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baer, P; Cinatl, J; Koch, B; Michaelis, M; Michel, D; Rabenau, H; Rothweiler, F; Schmidt, D; Schmidt, S; Stamminger, T; Vogel, JU | 1 |
Brighton, TA; Joseph, JE; Matthews, GV; Simpson, JD | 1 |
2 other study(ies) available for hydrazine and Cytomegalovirus
Article | Year |
---|---|
The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron Chelation.
Topics: Animals; Benzoates; Cells, Cultured; Cytomegalovirus; Drug Synergism; Fibroblasts; Ganciclovir; Humans; Hydrazines; Iron Chelating Agents; Mesenchymal Stem Cells; Mice; NIH 3T3 Cells; Pyrazoles; Virus Replication | 2019 |
Cytomegalovirus-associated thrombocytopenia treated with thrombopoietin receptor agonist.
Topics: Antiviral Agents; Benzoates; Cytomegalovirus; Cytomegalovirus Infections; Female; Humans; Hydrazines; Middle Aged; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Thrombopoietin | 2016 |